Keros Therapeutics Inc (KROS)
60.35
-2.72
(-4.31%)
USD |
NASDAQ |
Nov 14, 16:00
60.35
0.00 (0.00%)
After-Hours: 17:19
Keros Therapeutics Market Cap: 2.445B for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 2.555B |
| November 12, 2024 | 2.628B |
| November 11, 2024 | 2.761B |
| November 08, 2024 | 2.751B |
| November 07, 2024 | 2.721B |
| November 06, 2024 | 2.692B |
| November 05, 2024 | 2.535B |
| November 04, 2024 | 2.428B |
| November 01, 2024 | 2.428B |
| October 31, 2024 | 2.351B |
| October 30, 2024 | 2.341B |
| October 29, 2024 | 2.361B |
| October 28, 2024 | 2.384B |
| October 25, 2024 | 2.385B |
| October 24, 2024 | 2.338B |
| October 23, 2024 | 2.277B |
| October 22, 2024 | 2.329B |
| October 21, 2024 | 2.367B |
| October 18, 2024 | 2.405B |
| October 17, 2024 | 2.398B |
| October 16, 2024 | 2.441B |
| October 15, 2024 | 2.371B |
| October 14, 2024 | 2.375B |
| October 11, 2024 | 2.347B |
| October 10, 2024 | 2.269B |
| Date | Value |
|---|---|
| October 09, 2024 | 2.276B |
| October 08, 2024 | 2.343B |
| October 07, 2024 | 2.360B |
| October 04, 2024 | 2.391B |
| October 03, 2024 | 2.352B |
| October 02, 2024 | 2.407B |
| October 01, 2024 | 2.347B |
| September 30, 2024 | 2.280B |
| September 27, 2024 | 2.118B |
| September 26, 2024 | 2.134B |
| September 25, 2024 | 2.118B |
| September 24, 2024 | 2.086B |
| September 23, 2024 | 2.046B |
| September 20, 2024 | 2.094B |
| September 19, 2024 | 2.151B |
| September 18, 2024 | 2.090B |
| September 17, 2024 | 2.065B |
| September 16, 2024 | 2.087B |
| September 13, 2024 | 2.138B |
| September 12, 2024 | 2.116B |
| September 11, 2024 | 2.054B |
| September 10, 2024 | 2.052B |
| September 09, 2024 | 2.022B |
| September 06, 2024 | 1.970B |
| September 05, 2024 | 2.014B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
385.32M
Minimum
Apr 08 2020
2.761B
Maximum
Nov 11 2024
1.290B
Average
1.238B
Median
Market Cap Benchmarks
| Eli Lilly and Co | 746.23B |
| Regeneron Pharmaceuticals Inc | 85.87B |
| Scholar Rock Holding Corp | 2.200B |
| NovaBay Pharmaceuticals Inc | 3.555M |
| Palatin Technologies Inc | 20.92M |
Market Cap Related Metrics
| PS Ratio | 3233.35 |
| PEG Ratio | -2.205 |
| Price to Book Value | 4.588 |
| Price | 60.35 |
| Earnings Yield | -8.63% |
| PEGY Ratio | -2.205 |